Literature DB >> 22907420

Influence of process conditions on the crystallization and transition of metastable mannitol forms in protein formulations during lyophilization.

Wenjin Cao1, Yong Xie, Sampathkumar Krishnan, Hong Lin, Margaret Ricci.   

Abstract

PURPOSE: To study the impact of different process conditions and formulation compositions on metastable mannitol forms in protein formulations during lyophilization.
METHODS: Mannitol was studied with and without other formulation components. A cryostage was used to mimic the different processing steps during lyophilization. The different mannitol forms were monitored and quantified with an in situ Raman spectroscopic method. In addition, a Raman imaging method was developed to characterize the spatial distribution of mannitol forms in final lyophilization samples from the freeze-drying stage.
RESULTS: Amorphous mannitol was observed during fast cooling (10 °C/min) and with the addition of other formulation component. Amorphous mannitol crystallized into mainly δ and hemihydrate forms during annealing at -20 °C. Under vacuum without moisture, dried amorphous mannitol could transform to mainly α form at 45 °C and greater. The transformation mechanism of the hemihydrate mannitol was similar to that of amorphous form.
CONCLUSION: Mannitol tends to crystallize into stable crystalline forms by itself, but the addition of lyoprotectant (e.g. sucrose) and protein helps stabilize the metastable forms (hemihydrate and amorphous). The metastable forms are capable of transforming into mixtures of different forms, with heat and moisture being the critical processing factors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22907420     DOI: 10.1007/s11095-012-0855-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation.

Authors:  E D Breen; J G Curley; D E Overcashier; C C Hsu; S J Shire
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

2.  Existence of a mannitol hydrate during freeze-drying and practical implications.

Authors:  L Yu; N Milton; E G Groleau; D S Mishra; R E Vansickle
Journal:  J Pharm Sci       Date:  1999-02       Impact factor: 3.534

3.  Formulation and stability of freeze-dried proteins: effects of moisture and oxygen on the stability of freeze-dried formulations of human growth hormone.

Authors:  M J Pikal; K Dellerman; M L Roy
Journal:  Dev Biol Stand       Date:  1992

Review 4.  How does residual water affect the solid-state degradation of drugs in the amorphous state?

Authors:  E Y Shalaev; G Zografi
Journal:  J Pharm Sci       Date:  1996-11       Impact factor: 3.534

5.  Influence of the active pharmaceutical ingredient concentration on the physical state of mannitol--implications in freeze-drying.

Authors:  Xiangmin Liao; Rajesh Krishnamurthy; Raj Suryanarayanan
Journal:  Pharm Res       Date:  2005-08-31       Impact factor: 4.200

6.  Differentiation and quantitative determination of surface and hydrate water in lyophilized mannitol using NIR spectroscopy.

Authors:  Wenjin Cao; Chen Mao; Wendy Chen; Hong Lin; Sampathkumar Krishnan; Nina Cauchon
Journal:  J Pharm Sci       Date:  2006-09       Impact factor: 3.534

7.  The impact of protein concentration on mannitol and sodium chloride crystallinity and polymorphism upon lyophilization.

Authors:  Daniel Dixon; Serguei Tchessalov; Anthony Barry; Nicholas Warne
Journal:  J Pharm Sci       Date:  2009-09       Impact factor: 3.534

8.  Characterization of phase transitions during freeze-drying by in situ X-ray powder diffractometry.

Authors:  R K Cavatur; R Suryanarayanan
Journal:  Pharm Dev Technol       Date:  1998-11       Impact factor: 3.133

9.  Moisture-induced aggregation of lyophilized proteins in the solid state.

Authors:  W R Liu; R Langer; A M Klibanov
Journal:  Biotechnol Bioeng       Date:  1991-01-20       Impact factor: 4.530

10.  Effect of mannitol crystallinity on the stabilization of enzymes during freeze-drying.

Authors:  K Izutsu; S Yoshioka; T Terao
Journal:  Chem Pharm Bull (Tokyo)       Date:  1994-01       Impact factor: 1.645

View more
  4 in total

1.  Nanobubbles in Reconstituted Lyophilized Formulations: Interaction With Proteins and Mechanism of Formation.

Authors:  Jared R Snell; N S Krishna Kumar; Raj Suryanarayanan; Theodore W Randolph
Journal:  J Pharm Sci       Date:  2019-05-13       Impact factor: 3.534

2.  Intra-Vial Heterogeneity in Physical Form of Mannitol in Colyophilized Binary Systems.

Authors:  S Thakral; S Koranne; R Suryanarayanan
Journal:  Pharm Res       Date:  2018-09-21       Impact factor: 4.200

3.  Process and Formulation Effects on Protein Structure in Lyophilized Solids Using Mass Spectrometric Methods.

Authors:  Lavanya K Iyer; Gregory A Sacha; Balakrishnan S Moorthy; Steven L Nail; Elizabeth M Topp
Journal:  J Pharm Sci       Date:  2016-04-01       Impact factor: 3.534

4.  Development of thermostable lyophilized inactivated polio vaccine.

Authors:  Heleen Kraan; Paul van Herpen; Gideon Kersten; Jean-Pierre Amorij
Journal:  Pharm Res       Date:  2014-04-24       Impact factor: 4.200

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.